Back to CVE records
Medium 4.3HealthcarePublished May 31, 2026

CVE-2026-10173Orthanc Explorer 2 URL StudyList.vue cross site scripting

Updated under an hour ago ()

Does this affect you?

It affects Orthanc Explorer 2. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.28%, higher than 19% of scored CVEs.

A weakness has been identified in Orthanc Explorer 2 up to 1.12.0. The impacted element is an unknown function of the file WebApplication/src/components/StudyList.vue of the component URL Handler. This manipulation of the argument remote-source causes cross site scripting. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be used for attacks. Patch name: 21f78ce5da668bf5233efcd1896ec7c6e3b22eae. Applying a patch is the recommended action to fix this issue.

CVSS
4.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N/E:P/RL:O/RC:C
Weakness (CWE)
CWE-79, CWE-94
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.28% (percentile 19)
Assigned by
VulDB
NVD analysis
Deferred
Record last updated
Jun 1, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Orthanc Explorer 2
orthanc:explorer_2
1.0; 1.1; 1.2; 1.3; 1.4; 1.5; 1.6; 1.7; and 5 more ranges
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • exploit, issue-tracking
  • patch

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.